These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36146528)

  • 1. The Race for COVID-19 Vaccines: Accelerating Innovation, Fair Allocation and Distribution.
    Daems R; Maes E
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving Global Vaccine Equity: The Case for an International Pandemic Treaty.
    Jecker NS
    Yale J Biol Med; 2022 Jun; 95(2):271-280. PubMed ID: 35782474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine nationalism is not unethical from a political ethics perspective: Learning from the global COVID-19 vaccine distribution failure.
    Shao Q
    Health Policy; 2024 Mar; 141():104996. PubMed ID: 38266331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical development and approval of COVID-19 vaccines.
    Kalinke U; Barouch DH; Rizzi R; Lagkadinou E; Türeci Ö; Pather S; Neels P
    Expert Rev Vaccines; 2022 May; 21(5):609-619. PubMed ID: 35157542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors, enablers and challenges for COVID-19 vaccine development.
    Excler JL; Saville M; Privor-Dumm L; Gilbert S; Hotez PJ; Thompson D; Abdool-Karim S; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
    Lie RK; Miller FG
    Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalue ethical framework for fair global allocation of a COVID-19 vaccine.
    Liu Y; Salwi S; Drolet BC
    J Med Ethics; 2020 Aug; 46(8):499-501. PubMed ID: 32532826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inequity in access to vaccines: the failure of the global response to the COVID-19 pandemic.
    Ugalde A; Hellmann F; Homedes N
    Salud Colect; 2022 Oct; 18():e4190. PubMed ID: 36520487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
    Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
    Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.
    Aripov T; Wikler D; Asadov D; Tulekov Z; Murzabekova T; Munir KM
    BMC Med Ethics; 2022 Mar; 23(1):21. PubMed ID: 35264173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct from the COVID-19 crisis: research and innovation sparks in Brazil.
    Rosa MFF; da Silva EN; Pacheco C; Diógenes MVP; Millett C; Gadelha CAG; Santos LMP
    Health Res Policy Syst; 2021 Jan; 19(1):10. PubMed ID: 33478499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator.
    Saxena A; Baker BK; Banda A; Herlitz A; Miller J; Karrar K; Fleurbaey M; Chiwa E; Atuire CA; Hirose I; Hassoun N
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics.
    Martin R; Maleche A; Gay J; Fatima H
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38167259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constructing an ethical framework for priority allocation of pandemic vaccines.
    Fielding J; Sullivan SG; Beard F; Macartney K; Williams J; Dawson A; Gilbert GL; Massey P; Crooks K; Moss R; McCaw JM; McVernon J
    Vaccine; 2021 Jan; 39(5):797-804. PubMed ID: 33408013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R&D during public health emergencies: the value(s) of trust, governance and collaboration.
    Katz RA; Salamanca-Buentello F; Silva DS; Upshur RE; Smith MJ
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35346953
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.